Applications published 2 November 2006

Combination of a NMDA receptor antagonist and a MAO-inhibitor or a GADPH-inhibitor for the treatment of central nervous system related conditions
Neuromolecular 1715843*

Films for use as dosage forms
BioProgress Technology 1715844*

Dissolvable film comprising an active ingredient and method of manufacture
National Starch and Chemical Investment Holding 1715845*

Dissolvable film and method of manufacture
National Starch and Chemical Investment Holding 1715846*

Self-microemulsifying drug delivery systems of an HIV protease inhibitor
Tibotec Pharmaceuticals 1715847*

Microemulsion formulations comprising particular substance P antagonists
Novartis 1715848*

Stable pharmaceutical solution formulation for pressurised metered dose inhalers
Chiesi Farmaceutici 1715849*

Pharmaceutical compsn for oral application and method for preparing thereof
Mattern, Udo 1715850*

Consumer customised dosage forms
McNeil-PPC 1715851*

Non-disintegrating oral solid compsn of high dose of water soluble drugs
Panacea Biotec 1715852*

Compsns for delivering hypnotic agents across the oral mucosa and methods of use thereof
Transoral Pharmaceuticals 1715853*

Prodrugs for the intravenous administration of proton pump inhibitors
Allergan 1715854*

Anti-viral therapeutics
Elixir Pharmaceuticals 1715855*

Atometoxine formulations
Actavis Group 1715856*

Amidine derivatives for treating amyloidosis
Neurochem (International) 1715857*

Topical treatment of otitis externa with antifungals or antibacterials
Farifield Clinical Trials 1715858*

Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
Hedner, Jan; Grote, Ludger; Stenloef, Kaj 1715859*

Combination of benzothiazol-2-one beta2 adrenoceptor agonists and corticosteroids for the treatment of respiratory diseases
Novartis 1715860*

Compsn comprising prodrugs of proton pump inhibitors
Allergan 1715861*

Kinase inhibitors
Devgen 1715862*

Enhancement of ampakine-induced facilitation of synaptic responses by cholinesterase inhibitors
Cortex Pharmaceuticals; The Regents of the University of California 1715863*

Use of siramesine in the treatment of cancer
H Lundbeck 1715864*

Hyperlipidemia therapeutic agent comprising pitastatins and eicosapentaenoic acid
Kowa Company; Nissan Chemical Industries 1715865*

Protease inhibitors for the treatment of wrinkles
The General Hospital Corp; Research Foundation of the University of Central Florida 1715866*

Bipyridyl amides as modulators of metabotropic glutamate receptor-5
Merck 1715867*

Combinations of an atypical antipsychotic and an aminomethylpyridyloxymethyl/benzisoxazole asabicyclic derivative for treating CNS disorders
Pfizer 1715868*

Method of stimulating hair growth
Warner-Lambert 1715869*

Inhibition of protein kinase C-related kinase (PRK) as a treatment for cardiac hypertrophy and heart failure
Myogen; Board of Regents, The University of Texas System; The Regents of the University of Colorado 1715870*

Kinase inhibitor phosphonate conjugates
Gilead Sciences 1715871*

Improved therapy using a combination of raloxifene and alendronate
Teva Pharmaceutical Industries 1715872*

Nucleoside phosphonate derivatives useful in the treatment of HIV infections
LG Life Sciences 1715873*

Spermicidal preparations and uses thereof
Conve 1715874*

Systems and methods related to degradation of uremic toxins
Brown University 1715875*

New synbiotic use
Synbiotics 1715876*

Compsns and methods for reducing cholesterol comprising guggul and beta-glucan and/or plant sterols
Cargill 1715877*

Use of an extract of pueraria tuberosa for the treatment of diabetes type 2
Council of Scientific and Industrial Research 1715878*

Onion extracts
Divapharma 1715879*

An efficient method to synthesise benzyl group-protected alpha-pentagalloylglucose (a-PGG) and its analogues
Ohio University 1715880*

Cysteine rich peptides for improving thiol homeostasis
Campina Nederland Holding 1715881*

SMAC peptidomimetics and the uses thereof
The Regents of the University of Michigan 1715882*

18-membered nitrobenzyl-substituted and aminobenzyl-substituted cyclohexadepsi-peptides for controlling endoparasites. and method for the production thereof
Bayer Healthcare 1715883*

Chaperonin 10 modulation of toll-like receptor0inducible cytokine and chemokine secretion
CBIO 1715884*

Compsns and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
Nastech Pharmaceutical 1715885*

Hydrocephalus treatment
Shinshu 1715886*

N-terminally monopegylated human growth hormone conjugates, process for their preparation and methods of use thereof
Pharmacia 1715887*

Treatment of abnormalities of the first metatarsophalangeal joint of the foot
Radovic, Philip 1715888*

Regulatory T cells suppress autoimmunity
Regents of the University of California 1715889*

CTGF as target for the therapy of diabetic neuropathy
Fibrogen 1715890*

Methods of treating osteoarthritis with anti-IL6 or anti-IL6 receptor antibodies
Warner-Lambert 1715891*

Methods and compsns for modulating angiogenesis
ChemoCentryx 1715892*

Direct compression formulation and process
Novartis Pharma 1715893*

Stable garbapentin compsns
Ivax; Noerton Healthcare 1715894*

Chemically modified human growth hormone receptor antagonist conjugates
Pharmacia 1715895*

Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in combination therapies for the treatment of cancer
GeneSense Technologies 1715896*

High frequency ultrasound imaging using contrast agents
Sunnybrook and Women's College Health Sciences Centre 1715897*